Work

Abstract 6650: Targeting the PI3K pathway with alpelisib in patient-derived xenografts: a multi-cancer type approach

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-6650

Authors: Kapur B. Dhami, Chiya-Kuei Mo, Zhanfang Guo, Richard Kurupi, Preet Lal, Kazuhito Soto, Xiyi Wei, Michael C. Wendl, Jacqueline Mudd, Shunqiang Li, Sherri R. Davies, Jeff Chuang, Bingliang Fang, Ryan Fields, Hui Zhang, Meenhard Herlyn, Feng Chen, Kian-Huat Lim, Kian-Huat Lim, Cynthia Ma, Li DIng

Institutions: Washington University in St. Louis, The Jackson Laboratory for Genomic Medicine, The University of Texas MD Anderson Cancer Center, Johns Hopkins University, The Wistar Institute

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409634781

Cites:

Cited by:

Related to: 10